LUCY (Innovative Eyewear, Inc. Common Stock) Stock Analysis - News
Innovative Eyewear, Inc. Common Stock (LUCY) is a publicly traded Healthcare sector company. As of May 21, 2026, LUCY trades at $0.95 with a market cap of $5.92M and a P/E ratio of -0.56. LUCY moved +0.00% today. Year to date, LUCY is -12.80%; over the trailing twelve months it is -65.86%. Its 52-week range spans $0.90 to $10.40. Analyst consensus is buy with an average price target of $3.00. Rallies surfaces LUCY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What changed in LUCY news today?
Innovative Eyewear Q1 Revenue Soars 70% to $773,561, Net Loss Widens: First-quarter net revenue rose 70% to $773,561, marking an 11th straight quarter of growth driven by Lucyd Armor® safety glasses, which made up two-thirds of unit sales. Net loss widened to $2.31 million ($0.37 per share) as operating expenses increased 20%, with gross margin steady at 23%.
Innovative Eyewear Q1 Revenue Soars 70% to $773,561, Net Loss Widens: First-quarter net revenue rose 70% to $773,561, marking an 11th straight quarter of growth driven by Lucyd Armor® safety glasses, which made up two-thirds of unit sales. Net loss widened to $2.31 million ($0.37 per share) as operating expenses increased 20%, with gross margin steady at 23%.
Does Rallies summarize LUCY news?
Yes. Rallies summarizes LUCY news with ticker-specific context, catalysts, source links, and AI-generated market summaries when news is available.
Is LUCY research on Rallies investment advice?
No. Rallies provides research, data, and educational context for LUCY. It does not provide personalized investment advice.
